IGF1 and prostate carcinoma: For example, PSA cleaves insulin-like growth factor binding proteins resulting in local release of IGF-1 (Cohen et al, 1994), which has been positively associated with prostate cancer risk (Chan et al, 1998; Stattin et al, 2000).